We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




PerkinElmer Acquires Labtronics, Provider of Lab Notebook Solutions

By LabMedica International staff writers
Posted on 24 May 2011
PerkinElmer's (Waltham, MA, USA) software company has bought the electronic laboratory notebook provider Labtronics (Guelph, Canada). More...
Labtronics provides procedure-based electronic laboratory notebook (ELN) solutions for laboratories performing routine analysis in multiple industries. Financial details of the deal were not disclosed.

The Labtronics acquisition follows the purchase of informatics companies CambridgeSoft and ArtusLabs by PerkinElmer in March 2011 for US$220 million. CambridgeSoft and ArtusLabs anticipate combined revenues of about $65 million, according to PerkinElmer, which finished 2010 with about $1.7 billion in revenue.

The addition of Labtronics' solutions extends PerkinElmer's ELN and data-integration software offerings into laboratories following strict routine procedures such as regulated and nonregulated quality assurance/quality control (QA/QC), late-stage product or method development laboratories, and environmental and food testing labs. Labtronics' tools can be applied to any procedure-based problem including laboratory analysis, equipment calibration, and validation, and cleaning validation, notes PerkinElmer.

Dusty Tenney, president, analytical sciences and laboratory services, PerkinElmer said, "This acquisition successfully positions PerkinElmer as the only technology provider able to deploy an optimized ELN solution across a global customer's entire value chain, from research to manufacturing."

Mr Tenney added, "The acquisition presents strong synergies with our OneSource Laboratory Services portfolio providing enterprise-level solutions that foster long-term partnerships with customers."

Related Links:
PerkinElmer
Labtronics




New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.